Gene discovery in autism may represent an even greater challenge than in other conditions, such as hypertension or diabetes, however, due to the vagaries of diagnosis, particularly at the boundaries of the syndrome, and the current absence of any biomarker that may reliably distinguish an affected from an unaffected individual.